These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Non-thermal plasma for inactivated-vaccine preparation. Wang G, Zhu R, Yang L, Wang K, Zhang Q, Su X, Yang B, Zhang J, Fang J. Vaccine; 2016 Feb 17; 34(8):1126-32. PubMed ID: 26529075 [Abstract] [Full Text] [Related]
24. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza. Zhao J, Yang H, Xu H, Ma Z, Zhang G. Virol J; 2017 Mar 16; 14(1):56. PubMed ID: 28302119 [Abstract] [Full Text] [Related]
29. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus. Xu X, Xue C, Liu X, Li J, Fei Y, Liu Z, Mu J, Bi Y, Qian J, Yin R, Ding Z. Vet Microbiol; 2019 Jan 16; 228():173-180. PubMed ID: 30593364 [Abstract] [Full Text] [Related]
32. Purified precipitated virus obtained by a new simple method. TAKATSY G. Acta Med Acad Sci Hung; 1952 Jan 16; 3(2):185-91. PubMed ID: 13007362 [No Abstract] [Full Text] [Related]
34. [Disinfection of influenza, mumps and Newcastle viruses in protein-free medium]. GRAFE A, HAUSSMANN HG. Z Hyg Infektionskr; 1956 Jan 16; 143(3):278-303. PubMed ID: 13401975 [No Abstract] [Full Text] [Related]
35. Detection and differentiation of Newcastle disease virus and influenza virus by using duplex real-time PCR. Nidzworski D, Wasilewska E, Smietanka K, Szewczyk B, Minta Z. Acta Biochim Pol; 2013 Jan 16; 60(3):475-80. PubMed ID: 24040628 [Abstract] [Full Text] [Related]